HFM
MRK icon

Hartford Funds Management’s Merck MRK Stock Holding History

Hartford Funds Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
8,223
-81
-1% -$9.48K 0.08% 72
2026
Q1 		$999K Buy
8,304
+335
+4% +$38.7K 0.09% 68
2025
Q4 		$839K Buy
7,969
+259
+3% +$24.3K 0.07% 73
2025
Q3 		$647K Sell
7,710
-1,450
-16% -$119K 0.06% 74
2025
Q2 		$725K Sell
9,160
-4,229
-32% -$336K 0.06% 71
2025
Q1 		$1.2M Buy
13,389
+1,353
+11% +$126K 0.11% 34
2024
Q4 		$1.2M Sell
12,036
-891
-7% -$91.9K 0.11% 31
2024
Q3 		$1.47M Buy
12,927
+61
+0.5% +$7.25K 0.14% 19
2024
Q2 		$1.59M Buy
12,866
+1,079
+9% +$139K 0.15% 16
2024
Q1 		$1.56M Buy
11,787
+1,597
+16% +$197K 0.15% 16
2023
Q4 		$1.11M Buy
10,190
+2,010
+25% +$209K 0.11% 19
2023
Q3 		$842K Buy
8,180
+707
+9% +$76.2K 0.09% 15
2023
Q2 		$862K Buy
7,473
+3,428
+85% +$389K 0.09% 14
2023
Q1 		$430K Buy
4,045
+786
+24% +$84.9K 0.04% 32
2022
Q4 		$362K Buy
+3,259
New +$333K 0.04% 33

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hartford Funds Management's MRK Position: Q2 2026 in Review

Hartford Funds Management reduced its Merck (MRK) stake by 0.98% in Q2 2026, selling an estimated $9.48K and leaving 8,223 shares worth $1.06M. The position accounts for 0.08% of the portfolio, ranked #72.

Hartford Funds Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.59M in Q2 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hartford Funds Management held 8,223 shares of Merck worth $1.06M as of Q2 2026.
  • Hartford Funds Management sold 81 Merck shares in Q2 2026, an estimated $9.48K.
  • Merck made up 0.08% of Hartford Funds Management's portfolio in Q2 2026, its #72 holding.
  • Hartford Funds Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Hartford Funds Management's Merck position peaked at $1.59M in Q2 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hartford Funds Management's 13F filing for Q2 2026, filed 6 Aug 2026.